224 related articles for article (PubMed ID: 17204701)
1. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
2. Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Xu J; Yang J; Miao Y
Nucl Med Biol; 2015 Apr; 42(4):369-74. PubMed ID: 25577037
[TBL] [Abstract][Full Text] [Related]
3. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
4. Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.
Yang J; Flook AM; Feng C; Miao Y
Bioorg Med Chem Lett; 2014 Jan; 24(1):195-8. PubMed ID: 24316121
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting.
Yang J; Xu J; Cheuy L; Gonzalez R; Fisher DR; Miao Y
Mol Pharm; 2019 Apr; 16(4):1694-1702. PubMed ID: 30763112
[TBL] [Abstract][Full Text] [Related]
6. Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting.
Chen J; Cheng Z; Miao Y; Jurisson SS; Quinn TP
Cancer; 2002 Feb; 94(4 Suppl):1196-201. PubMed ID: 11877745
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
[TBL] [Abstract][Full Text] [Related]
8. Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [
Qiao Z; Xu J; Gonzalez R; Miao Y
Bioconjug Chem; 2023 May; 34(5):934-940. PubMed ID: 37140963
[TBL] [Abstract][Full Text] [Related]
9. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy.
Miao Y; Owen NK; Whitener D; Gallazzi F; Hoffman TJ; Quinn TP
Int J Cancer; 2002 Oct; 101(5):480-7. PubMed ID: 12216078
[TBL] [Abstract][Full Text] [Related]
11. Novel Al
Qiao Z; Xu J; Gonzalez R; Miao Y
Bioconjug Chem; 2022 May; 33(5):982-990. PubMed ID: 35475603
[TBL] [Abstract][Full Text] [Related]
12. Novel
Qiao Z; Xu J; Gonzalez R; Miao Y
Mol Pharm; 2022 Jul; 19(7):2535-2541. PubMed ID: 35486894
[TBL] [Abstract][Full Text] [Related]
13. Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues.
Cheng Z; Chen J; Miao Y; Owen NK; Quinn TP; Jurisson SS
J Med Chem; 2002 Jul; 45(14):3048-56. PubMed ID: 12086490
[TBL] [Abstract][Full Text] [Related]
14. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
15. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
16. Detection of pulmonary metastases with the novel radiolabeled molecular probe, (99m)Tc-RRL.
Yao N; Yan P; Wang RF; Zhang CL; Ma C; Chen XQ; Zhao Q; Hao P
Int J Clin Exp Med; 2015; 8(2):1726-36. PubMed ID: 25932101
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
19. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.
Kameyama K; Vieira WD; Tsukamoto K; Law LW; Hearing VJ
Int J Cancer; 1990 Jun; 45(6):1151-8. PubMed ID: 2161802
[TBL] [Abstract][Full Text] [Related]
20. Peptide-targeted radionuclide therapy for melanoma.
Miao Y; Quinn TP
Crit Rev Oncol Hematol; 2008 Sep; 67(3):213-28. PubMed ID: 18387816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
